Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

takeda malaysia sdn bhd - von willebrand factor; human blood coagulation factor viii -

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

baxter ag - human blood coagulation factor viii/von willebrand factor(vwf:rco) - powder and solvent for solution for injection - 250iu/190iu

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

baxter ag - human blood coagulation factor viii/von willebrand factor(vwf:rco) - powder and solvent for solution for injection - 500iu/375iu

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

baxter ag - human blood coagulation factor viii/von willebrand factor(vwf:rco) - powder and solvent for solution for injection - 1000iu/750iu

Australia - English - Department of Health (Therapeutic Goods Administration)

vaccinia virus -

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - japanese encephalitis vaccine 6 units - suspension for injection - 6 u/dose - active: japanese encephalitis vaccine 6 units excipient: aluminium hydroxide gel dibasic sodium phosphate monobasic potassium phosphate sodium chloride - jespect® is indicated for active immunisation against japanese encephalitis (je) virus for persons 18 years of age and older. jespect® should be considered for use in persons who plan to reside in or travel to areas where je is endemic (common) or epidemic (seasonal), especially during the transmission season. jespect® is indicated for persons who work with je virus in laboratories and in industry.

Israel - English - Ministry of Health

csl behring ltd., israel - c - 1 esterase inhibitor human - powder for solution for inj/inf - c - 1 esterase inhibitor human 500 iu/vial - c1- inhibitor,plasma derived - c1- inhibitor,plasma derived - hereditary angioedema type i and ii (hae).treatment and pre-procedure (prior to oral, dental, and upper respiratory tract procedures) prevention of acute episodes

Israel - English - Ministry of Health

kamada ltd, israel - human hepatitis b immunoglobulin - solution for injection - human hepatitis b immunoglobulin 500 iu - hepatitis b immunoglobulin - hepatitis b immunoglobulin - prevention of hepatitis b virus (hbv) re-infection in hbsag and hbv-dna negative adult patients at least one week after liver transplantation for hepatitis b induced liver failure.hbv-dna negative status should be confirmed within the last 3 months prior to olt. patients should be hbsag negative before treatment start.the concomitant use of adequate virostatic agents should be considered as standard of hepatitis b re-infection prophylaxis.

Malta - English - Medicines Authority

kedrion s.p.a loc. ai conti, 55051 castelvecchio pascoli, barga - lucca, italy - human normal, immunoglobulin - solution for infusion - human normal immunoglobulin 0.550 g/l - immune sera and immunoglobulins

European Union - English - EMA (European Medicines Agency)

csl behring gmbh - human normal immunoglobulin (scig) - immunologic deficiency syndromes - immune sera and immunoglobulins, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4.4).- secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of